Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand–Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib

Regorafenib confers the benefit of longer survival in metastatic colorectal cancer patients. The CCL5/CCR5 pathway modulates endothelial progenitor cell migration and vascular endothelial growth factor A production. Genetic variants of CCL4 and CCL3 may predict outcomes, and the different frequencie...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Colorectal Cancer
Auteurs principaux: Suenaga, Mitsukuni, Schirripa, Marta, Cao, Shu, Zhang, Wu, Yang, Dongyun, Ning, Yan, Cremolini, Chiara, Antoniotti, Carlotta, Borelli, Beatrice, Mashima, Tetsuo, Okazaki, Satoshi, Berger, Martin D., Miyamoto, Yuji, Gopez, Roel, Barzi, Afsaneh, Lonardi, Sara, Yamaguchi, Toshiharu, Falcone, Alfredo, Loupakis, Fotios, Lenz, Heinz-Josef
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7493703/
https://ncbi.nlm.nih.gov/pubmed/29606345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clcc.2018.02.010
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires